Enovis Corporation

NYSE ENOV

Enovis Corporation EBITDA for the Trailing 12 Months (TTM) ending September 27, 2024: USD -67.80 M

Enovis Corporation EBITDA is USD -67.80 M for the Trailing 12 Months (TTM) ending September 27, 2024, a -142.29% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Enovis Corporation EBITDA for the Trailing 12 Months (TTM) ending September 29, 2023 was USD 160.30 M, a -7.53% change year over year.
  • Enovis Corporation EBITDA for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 173.35 M, a -52.12% change year over year.
  • Enovis Corporation EBITDA for the Trailing 12 Months (TTM) ending October 01, 2021 was USD 362.08 M, a -14.26% change year over year.
  • Enovis Corporation EBITDA for the Trailing 12 Months (TTM) ending October 02, 2020 was USD 422.29 M, a 6.06% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
NYSE: ENOV

Enovis Corporation

CEO Mr. Matthew L. Trerotola
IPO Date May 8, 2008
Location United States
Headquarters 2711 Centerville Road
Employees 6,550
Sector Health Care
Industries
Description

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Similar companies

ITT

ITT Inc.

USD 143.55

2.91%

DCI

Donaldson Company, Inc.

USD 68.24

1.88%

IEX

IDEX Corporation

USD 214.54

2.15%

GRC

The Gorman-Rupp Company

USD 37.06

1.65%

NPO

EnPro Industries, Inc.

USD 166.69

1.93%

GHM

Graham Corporation

USD 42.87

1.18%

EPAC

Enerpac Tool Group Corp.

USD 42.43

1.85%

MIDD

The Middleby Corporation

USD 139.30

1.90%

KAI

Kadant Inc.

USD 354.31

1.67%

HLIO

Helios Technologies, Inc.

USD 44.41

1.74%

LXFR

Luxfer Holdings PLC

USD 12.80

2.24%

HURC

Hurco Companies, Inc.

USD 17.71

-3.01%

FELE

Franklin Electric Co., Inc.

USD 97.38

1.69%

WTS

Watts Water Technologies, Inc.

USD 202.72

1.74%

OFLX

Omega Flex, Inc.

USD 41.24

2.92%

StockViz Staff

January 15, 2025

Any question? Send us an email